Dr Clémence Granier from the Hôpital Européen Georges Pompidou in Paris (France) provides an overview on the rational to target immune checkpoints in various diseases.
Dr Clémence Granier from the Hôpital Européen Georges Pompidou in Paris (France) provides an overview on the rational to target immune checkpoints in various diseases.
Optimising treatment strategies and AE management
Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer
An overview of the EMERALD subgroup analyses
A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC
Survey findings presented at ONS 2025 and published in the journal Healthcare